Work

Zanzalintinib With Pembrolizumab and Cetuximab in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

Year: 2026

Type: article

Source: JCO oncology advances.

DOI: 10.1200/oa-26-00089

Authors: Wenji Guo, Noura Choudhury, Rachel Hartnett, Theodore Karrison, Jacquelyn Enriquez, Nishant Agrawal, Rohan Katipally, Aditya Juloori, Hassan Arshad, Chen Lin, Evgeny Izumchenko, Yuxuan Miao, Alexander Pearson, Everett Vokes, Ari J Rosenberg

Institution: University of Chicago

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

Funders: AstraZeneca, Ionis Pharmaceuticals, EMD Serono, Daiichi Sankyo Europe

OpenAlex ID: W7212000499

FWCI:

Cites: 10

Cited by:

Related to: 10